STRATEGIES FOR STUDYING BRAIN DISORDERS

Vol.7 Genes and Environment Interplay in Neuropsychiatric Disorders

Vol.7 Genes and Environment Interplay in Neuropsychiatric Disorders

Editors:Tomás Palomo, Richard J. Beninger, Trevor Archer, Richard M. Kostrzewa

December 2004

Publisher: Editorial CYM, General Oráa, 47, 28006 MADRID

ISBN: 84-934250-1-X

Pages: 575

Congresos

Genes and environment interplay in Neuropsychiatric Disorders

Mojácar (Almería)

October 16 - 20 2003

The content of this congress, together with other contributions on the topic, are collected in vol. 7 of the series "Strategies for studying brain disorders".

PROGRAMME

  • Tomas Palomo, Spain
    Opening Remarks
  • Bita Moghaddam, USA
    A few words in memory of Patricia Goldman-Rakic

S1. THE ROLE OF GENES AND ENVIRONMENT IN THE SHAPING OF BEHAVIOUR

  • Donald F. Klein, USA
    Genes, Environment and Psychiatry Nosology
  • Pier V. Piazza, France
    Environmental influence on genetic regulation of behaviour
  • Ayman Fanous, USA
    Genetic relationship between major depression, personality and schizophrenia
  • Jesús Avila, Spain
    Tau phosphorylation and assembly
  • Isidro Ferrer, Spain
    Participation of select active kinases in tau hyperphosphorylation in Alzheimer's disease, and in sporadic and familial taupathies
  • Peter Kalivas, USA
    Gene and environmental regulation of drug addiction:  can we forget to be addicted?

S2. SCHIZOPSYCHOTIC DISORDERS

  • Bita Moghaddam, USA
    Stress activation of glutamate neurotransmission in the prefrontal cortex: Implications for dopamine-associated disorders
  • Therese M. Jay, France
    Cellular mechanisms of hippocampal/frontal circuits
  • Gavin Reynolds, UK
    Calcium binding protein markers of GABA deficits in schizophrenia
  • Mark Geyer, USA
    Neurobiological measures of schizophrenia spectrum disorders
  • José Borrell, Spain
    Neurobiological consequences of prenatal immune challenge
  • Brien P. Riley, USA
    Linkage studies of schizophrenia
  • Robin Murray, UK
    The role of endophenotypic abnormalities in the relatives of people with schizophrenia

S3. COGNITIVES DISORDERS

  • Trevor Archer, Sweden
    Neurobehavioral deficits associated with apoptotic neurodegeneration and vulnerability for ADHD
  • Jorge H. Medina, Argentina
    Gene expression during memory formation
  • José M. Delgado-García, Spain
    The use of conscious mice in the study of learning and memory processes
  • Eduardo Rodriguez-Farré, Spain
    Xenobiotic-induced neuropsychiatric disorders: the case of methylmercury
  • Richard Beninger, Canada
    The role of signalling molecules in incentive learning
  • Martín Cammarota, Brazil
    Hippocampal glutamate receptors in fear memory consolidation
  • Ivan Izquierdo, Brazil
    The inhibition of acquired fear

S6. DRUG ABUSE

  • Javier Fernández, Spain
    Cannabinoids and gene expression during brain development
  • Janet Hoenicka, Spain
    CNR1 gene variants and behavioural disorders
  • Sari Izenwasser, USA
    The role of the dopamine transporter in cocaine abuse
  • Giancarlo Colombo, Italy
    Role of GABA-B receptor in alcohol dependence.
  • Gabriel Rubio, Spain
    Polymorphism TAq1 and alcohol dependence
  • Markus Heilig, Sweden
    Functional genomics strategies to identify susceptibility genes and treatment targets in alcohol dependence

S5. AFFECTIVE DISORDERS

  • Rene Hen, USA
    Influence of postnatal development and hippocampal neurogenesis on anxiety and depression
  • Antonio Bulbena, Spain
    Susceptibility factors in panic disorder
  • Jorge Manzanares, Spain
    Role of the endogenous cannabinoid CB1 receptor in the regulation of anxiety
  • Ian Reid, UK
    Synaptic plasticity and antidepressant treatment: New cells, new connections

S4. MOVEMENTS DISORDERS

  • Richard Kostrezwa, USA
    Dopamine agonist priming in intact and dopamine-lesioned rats: implications for motor dyskinesias
  • Alberto Ferrús, Spain
    Ariadne, a Parkin-related protein of Drosophila, regulates membrane biogenesis through the ubiquitin pathway
  • José Javier Lucas, Spain
    Neuronal induction of the immunoproteasome in Huntington’s disease

S7. FROM GENES TO BEHAVIOUR

  • Douglas Blackwood, UK
    Phenotypes and genotype at a chromosome 1q42 locus linked to schizophrenia and Bipolar Illness
  • Pierre Sokoloff, France
    Brain-derived neurotrophic factor (BDNF) bridges the gap between dopamine and glutamate dysfunctions in schizophrenia.
  • Cobi J. Heijnen, The Netherlands
    Neonatal glucocorticoids and the developing brain: short-term treatment with life-long consequences
  • Peter Eriksson, Sweden
    The spectre of hope in the neurodegenerative diseases: therapeutic potential of stem cells
  • Anil K. Malhotra, USA
    Genetic and environmental factors in the treatment of neuropsychiatric disorders
  • Michel Le Moal, France
    Environmentally induced long-term structural changes: cues for functional orientation and vulnerabilities

Fundación Cerebro y Mente
c/ General Oraa, 47 - 1º E 28006 Madrid, España
Telf: +34 91 561 1267 Fax: +34 91 564 1817
http://www.cermente.com

Resolución mínima: 1024 x 768. Navegadores recomendados: Google Chrome / Firefox 3.5+ / Internet Explorer 9.0+ / Opera 9.0+ / Safari 3.0+